Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein - PubMed (original) (raw)
Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein
H Takahashi et al. J Exp Med. 1989.
Abstract
In H-2d mice, the immunodominant determinant of the HIV-1-IIIB gp160 envelope glycoprotein recognized by CD8+ CTL is represented by a 15-residue synthetic peptide (315-329: RIQRGPGRAFVTIGK). This peptide is seen in association with the Dd class I MHC molecule expressed on H-2k L cell fibroblast targets. We explored the structural requirements for CTL recognition of this peptide at the levels of both the peptide molecule and the class I MHC molecule. Using several transfectants expressing recombinant Dd/Ld molecules, we found that presentation of this epitope required both the alpha 1 and alpha 2 domains of the Dd molecule, in contrast to certain instances of allorecognition for which alpha 1 of Dd was sufficient in association with alpha 2 of Ld. Because this peptide derives from a hypervariable segment of the HIV envelope, substituted peptides could be used to define not only the structures affecting interaction of peptide with class I MHC molecule and with the TCR, but also the structural basis for the effect of naturally occurring viral variation on CTL recognition. The CTL-LINE specific for this HIV-1-IIIB-derived sequence could not recognize the HIV-1-RF variant-derived sequence from exactly the same site (315-329:--HIGPGRVIYATGQ). Peptides with single amino acid substitutions from the HIV-1-IIIB sequence toward the HIV-1-RF sequence were made to test the effect of each residue significantly affected recognition, and only one, 324(F), was obligatory. Moreover, both 322(R) and 324(F) substituted peptides failed to inhibit the binding of the wild type peptide to the MHC molecule. Therefore, the amino-acids 322(R) and 324(F) seem to be involved in regulating peptide interaction with the Dd class I MHC molecule. In contrast, 325(V) appeared to affect interaction with the TCR. We suggest that sequence variations among known HIV-1 isolates that affect peptide binding to MHC such as those described here, if occurring during the course of infection of an individual, could result in failure of the MHC molecules of that individual to present the peptide. If the number of dominant HIV CTL epitopes is indeed very limited, such a blind spot could allow the virus to escape immune control, proliferate rapidly, and cause AIDS.
Similar articles
- Cytotoxic T cell repertoire selection. A single amino acid determines alternative class I restriction.
Bergmann CC, Tong L, Cua RV, Sensintaffar JL, Stohlman SA. Bergmann CC, et al. J Immunol. 1994 Jun 15;152(12):5603-12. J Immunol. 1994. PMID: 7515908 - AIDS pathogenesis: HIV envelope and its interaction with cell proteins.
Habeshaw JA, Dalgleish AG, Bountiff L, Newell AL, Wilks D, Walker LC, Manca F. Habeshaw JA, et al. Immunol Today. 1990 Nov;11(11):418-25. doi: 10.1016/0167-5699(90)90162-3. Immunol Today. 1990. PMID: 2078296 Review.
Cited by
- Charge-based interactions through peptide position 4 drive diversity of antigen presentation by human leukocyte antigen class I molecules.
Jackson KR, Antunes DA, Talukder AH, Maleki AR, Amagai K, Salmon A, Katailiha AS, Chiu Y, Fasoulis R, Rigo MM, Abella JR, Melendez BD, Li F, Sun Y, Sonnemann HM, Belousov V, Frenkel F, Justesen S, Makaju A, Liu Y, Horn D, Lopez-Ferrer D, Huhmer AF, Hwu P, Roszik J, Hawke D, Kavraki LE, Lizée G. Jackson KR, et al. PNAS Nexus. 2022 Jul 27;1(3):pgac124. doi: 10.1093/pnasnexus/pgac124. eCollection 2022 Jul. PNAS Nexus. 2022. PMID: 36003074 Free PMC article. - Japanese Kampo Medicine Juzentaihoto Enhances Antitumor Immunity in CD1d-/- Mice Lacking NKT Cells.
Takaku S, Shimizu M, Takahashi H. Takaku S, et al. Integr Cancer Ther. 2020 Jan-Dec;19:1534735419900798. doi: 10.1177/1534735419900798. Integr Cancer Ther. 2020. PMID: 31959018 Free PMC article. - Effects of Cross-Presentation, Antigen Processing, and Peptide Binding in HIV Evasion of T Cell Immunity.
Frey BF, Jiang J, Sui Y, Boyd LF, Yu B, Tatsuno G, Billeskov R, Solaymani-Mohammadi S, Berman PW, Margulies DH, Berzofsky JA. Frey BF, et al. J Immunol. 2018 Mar 1;200(5):1853-1864. doi: 10.4049/jimmunol.1701523. Epub 2018 Jan 26. J Immunol. 2018. PMID: 29374075 Free PMC article. - CD47 in the tumor microenvironment limits cooperation between antitumor T-cell immunity and radiotherapy.
Soto-Pantoja DR, Terabe M, Ghosh A, Ridnour LA, DeGraff WG, Wink DA, Berzofsky JA, Roberts DD. Soto-Pantoja DR, et al. Cancer Res. 2014 Dec 1;74(23):6771-83. doi: 10.1158/0008-5472.CAN-14-0037-T. Epub 2014 Oct 8. Cancer Res. 2014. PMID: 25297630 Free PMC article. - Immunogenic properties of a lettuce-derived C4(V3)6 multiepitopic HIV protein.
Govea-Alonso DO, Rubio-Infante N, García-Hernández AL, Varona-Santos JT, Korban SS, Moreno-Fierros L, Rosales-Mendoza S. Govea-Alonso DO, et al. Planta. 2013 Oct;238(4):785-92. doi: 10.1007/s00425-013-1932-y. Epub 2013 Jul 30. Planta. 2013. PMID: 23897297
References
- J Immunol. 1986 Dec 15;137(12):3881-90 - PubMed
- Immunol Rev. 1988 Dec;106:5-31 - PubMed
- Nature. 1987 Jan 29-Feb 4;325(6103):450-2 - PubMed
- Science. 1987 Mar 13;235(4794):1353-8 - PubMed
- J Immunol. 1987 Apr 1;138(7):2213-29 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials